您当前的位置:
首页 >
文章列表页 >
Excellent effects and possible mechanisms of action of a new antibody–drug conjugate against EGFR-positive triple-negative breast cancer
Excellent effects and possible mechanisms of action of a new antibody–drug conjugate against EGFR-positive triple-negative breast cancer
Excellent effects and possible mechanisms of action of a new antibody–drug conjugate against EGFR-positive triple-negative breast cancer
- 解放军医学杂志(英文版) 2022年9卷第4期 页码:419-431
DOI: 10.1186/s40779-021-00358-9
移动端阅览
HTML全文
图( 7 ) 表( 0 )
参考文献
出版信息
数据统计
14
浏览量
22
下载量
1
CSCD
文章被引用时,请邮件提醒。
提交
工具集
- BibTeX下载
- Endnote下载
- RefMan 下载
- NoteExpress下载
- NoteFirst下载
相关文章
Crosstalk in the brain tumor microenvironment: mechanisms, therapeutic strategies, and clinical advances
Reprogramming neural-tumor crosstalk: emerging therapeutic dimensions and targeting strategies
The efficacy of tucatinib-based therapeutic approaches for HER2-positive breast cancer
Expression of epidermal growth factor and its receptor in gestational trophoblastic diseases
Metabolic syndrome and risk of sepsis and sepsis-related mortality: evidence from two large prospective cohort studies
相关作者
Liu Chen
Rong-Rong Zhou
Paul R Lockman
Thomas Michael Marti
Hai-Bin Deng
Mu-Yuan Jia
Jie Yang
Ke-Qin Zhang
相关机构
Department of Radiation Oncology, Hunan Cancer Hospital/Affiliated Hospital of Xiangya School of Medicine, Central South University
Xiangya Lung Cancer Center, Xiangya Hospital, Central South University
Department of Neuroscience, West Virginia University School of Medicine, Rockefeller Neuroscience Institute
Department of Pharmaceutical Sciences, West Virginia University School of Pharmacy
Department for BioMedical Research, University of Bern

